ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
DTE Energy Company
51.37
0.0000
成交量：
- -
成交额：
- -
市值：
98.93亿
市盈率：
8.14
高：
51.37
开：
51.37
低：
51.37
收：
51.37
52周最高：
54.73
52周最低：
47.05
股本：
1.93亿
流通股本：
1.91亿
量比：
- -
换手率：
- -
股息：
3.85
股息率：
7.49%
每股收益(TTM):
6.31
每股收益(LYR):
6.31
净资产收益率：
10.39%
总资产收益率：
2.72%
市净率：
0.85
市盈率(LYR):
8.14
数据加载中...
总览
公司
新闻资讯
公告
新股前瞻|布局稀缺抗癌赛道，英派药业IPO故事有多少看点？
智通财经
·
2025/10/06
国控、华润、九州通、华东医药业绩新鲜出炉
医药经济报
·
2025/08/27
华润医药新总裁上任
药智网
·
2025/08/27
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DTP/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"DTP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DTP\",,,,,undefined,":{"symbol":"DTP","market":"US","secType":"STK","nameCN":"DTE Energy Company","latestPrice":51.37,"timestamp":1729886400000,"preClose":51.37,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":191263476,"shares":192581931,"eps":6.308108,"marketStatus":"盘前交易","change":0,"latestTime":"02-24 08:13:31 EST","open":51.37,"high":51.37,"low":51.37,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.308108,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771943400000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":51.37,"dividendRate":0.074898,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DTP\",,,,,undefined,":{"symbol":"DTP","floatShares":191263476,"roa":"2.72%","roe":"10.39%","lyrEps":6.308108,"shares":192581931,"dividePrice":3.8475,"high":51.37,"amplitude":0,"preClose":51.37,"low":51.37,"week52Low":47.05,"pbRate":"0.85","week52High":54.7275,"institutionHeld":0.3036,"latestPrice":51.37,"eps":6.308108,"divideRate":0.074898,"volume":0,"delay":0,"ttmEps":6.308108,"open":51.37,"prevYearClose":51.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DTP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-11-01","symbol":"DTP","reason":null,"defaultRemindTime":1667309400000,"announcedDate":"2022-10-28","type":"delisting","dateTimestamp":1667275200000},{"market":"US","date":"2022-10-14","symbol":"DTP","amount":0.78125,"defaultRemindTime":1665754200000,"name":"DTE Energy Company","recordDate":"2022-11-01","payableDate":"2022-10-17","currency":"USD","type":"dividend","dateTimestamp":1665720000000},{"market":"US","date":"2022-07-14","symbol":"DTP","amount":0.78125,"defaultRemindTime":1657805400000,"name":"DTE Energy Company","recordDate":"2022-08-01","payableDate":"2022-07-15","currency":"USD","type":"dividend","dateTimestamp":1657771200000},{"market":"US","date":"2022-04-13","symbol":"DTP","amount":0.78125,"defaultRemindTime":1649856600000,"name":"DTE Energy Company","recordDate":"2022-05-01","payableDate":"2022-04-14","currency":"USD","type":"dividend","dateTimestamp":1649822400000},{"market":"US","date":"2022-01-13","symbol":"DTP","amount":0.78125,"defaultRemindTime":1642084200000,"name":"DTE Energy Company","recordDate":"2022-02-01","payableDate":"2022-01-14","currency":"USD","type":"dividend","dateTimestamp":1642050000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DTP\",market:\"US\",,,undefined,":[{"executeDate":"2020-01-14","recordDate":"2020-01-15","paymentDate":"2020-02-01","value":0.78125,"currency":"USD"},{"executeDate":"2020-04-14","recordDate":"2020-04-15","paymentDate":"2020-05-01","value":0.78125,"currency":"USD"},{"executeDate":"2020-07-14","recordDate":"2020-07-15","paymentDate":"2020-08-01","value":0.78125,"currency":"USD"},{"executeDate":"2020-10-14","recordDate":"2020-10-15","paymentDate":"2020-11-01","value":0.78125,"currency":"USD"},{"executeDate":"2021-01-14","recordDate":"2021-01-15","paymentDate":"2021-02-01","value":0.78125,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DTP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DTP\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2573620525","title":"新股前瞻|布局稀缺抗癌赛道，英派药业IPO故事有多少看点？","url":"https://stock-news.laohu8.com/highlight/detail?id=2573620525","media":"智通财经","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573620525?lang=zh_cn&edition=fundamental","pubTime":"2025-10-06 16:21","pubTimestamp":1759738871,"startTime":"0","endTime":"0","summary":"为加速市场渗透并缓解资金压力，英派药业正从多维度推进塞纳帕利的商业化布局。其中PARP抑制剂作为首个在临床上获得成功的合成致死药物，全球已有6款获批上市，包括阿斯利康的奥拉帕利和恒瑞医药的氟唑帕利等。在这一赛道中，英派药业已建立起领先地位。然而，随着合成致死靶点热度攀升，行业竞争正日趋激烈。作为全球少数同时布局PARP1/2与新一代PARP1抑制剂的公司，英派药业已构筑起长期竞争壁垒，有望持续受益于该赛道的成长红利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1352400.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["DTP"],"gpt_icon":0},{"id":"2562778691","title":"国控、华润、九州通、华东医药业绩新鲜出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2562778691","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562778691?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 19:58","pubTimestamp":1756295916,"startTime":"0","endTime":"0","summary":"目前，除上海医药仅发布业绩预告外，国药控股、华润医药、重药控股以及华东医药等流通龙头已相继披露2025年半年报。在服务转型方面，国药控股持续开展营销服务、三方物流、SPD服务等服务类项目，截至2025年6月底，服务性收入持续增长，不断为国药控股带来业绩贡献。此外，国药控股和诺华将在产品引进、特药零售、全渠道营销和创新支付等领域扩大合作范围。期内华润医药的DTP业务实现收益约37.6亿元，同比增长约14.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827200908a6feff28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827200908a6feff28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DTP"],"gpt_icon":0},{"id":"2562710955","title":"华润医药新总裁上任","url":"https://stock-news.laohu8.com/highlight/detail?id=2562710955","media":"药智网","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562710955?lang=zh_cn&edition=fundamental","pubTime":"2025-08-27 15:42","pubTimestamp":1756280570,"startTime":"0","endTime":"0","summary":"华润系高管团队再度调整，东阿阿胶董事长程杰履新华润医药总裁。程杰此次履新属于职务晋升，这次任命后，其不仅进入华润医药核心决策层，更出任总裁，执掌日常经营管理，同时加入执行委员会与企业管治委员会。放眼整个华润系，郭霆自8月起代行华润医药商业董事长职责，其此前为华润三九副总裁；邬建军同月辞去董事长职务，已被任命为康佳集团党委书记。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827164715a4a21390&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250827164715a4a21390&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DTP"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}